scPharmaceuticals Inc.
NASDAQ:SCPH
3.38 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13.593 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.811 | 0.468 | 0.438 | 0.399 | 0.364 | 0.332 | 0.167 | 0.005 | 0.004 |
| Gross Profit
| 9.782 | -0.468 | -0.438 | -0.399 | -0.364 | -0.332 | -0.167 | -0.005 | -0.004 |
| Gross Profit Ratio
| 0.72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 11.809 | 15.533 | 16.039 | 18.149 | 24.632 | 15.948 | 14.331 | 11.856 | 8.267 |
| General & Administrative Expenses
| 53.369 | 20.624 | 9.784 | 11.784 | 8.273 | 13.719 | 9.105 | 6.054 | 2.577 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 53.369 | 20.624 | 9.784 | 11.784 | 8.273 | 13.719 | 9.105 | 6.054 | 2.577 |
| Other Expenses
| 0 | 1.418 | 0.315 | -0.004 | 0.016 | -0.056 | 0.075 | 0.038 | -0.068 |
| Operating Expenses
| 65.178 | 36.157 | 25.823 | 29.933 | 32.905 | 29.667 | 23.436 | 17.91 | 10.844 |
| Operating Income
| -55.396 | -36.157 | -25.823 | -29.933 | -32.905 | -29.667 | -23.436 | -17.91 | -10.844 |
| Operating Income Ratio
| -4.075 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.586 | -0.681 | -2.211 | -2.276 | -0.091 | 0.224 | -0.381 | -6.467 | 0.326 |
| Income Before Tax
| -54.81 | -36.838 | -28.034 | -32.209 | -32.996 | -29.443 | -23.817 | -24.377 | -10.518 |
| Income Before Tax Ratio
| -4.032 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.681 | 2.452 | 2.184 | 1.419 | -0.224 | 0.381 | 6.467 | -0.326 |
| Net Income
| -54.81 | -37.519 | -30.486 | -34.393 | -34.415 | -29.443 | -23.817 | -24.377 | -10.518 |
| Net Income Ratio
| -4.032 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.42 | -1.32 | -1.11 | -1.4 | -1.85 | -1.59 | -8.04 | -2.18 | -0.94 |
| EPS Diluted
| -1.42 | -1.32 | -1.11 | -1.4 | -1.85 | -1.59 | -8.04 | -2.18 | -0.94 |
| EBITDA
| -46.061 | -33.068 | -25.021 | -29.223 | -30.865 | -27.679 | -25.153 | -17.86 | -10.84 |
| EBITDA Ratio
| -3.389 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |